Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
The British Pharmaceutisical Giant Astrazeneca on Tuesday promises to continue investing and growing its business in the United States, beyond the possible tariffs of President Donald Trump.
“Our company is firmly committed to investing and increasing the US,” the chief executive Pascal Soriot said to an income statement, that the first quarter gain was raised by 30 percent of $ 2.92 billion.
The United States before April opens the door to potential tariffs that focuses pharmacies, which is more benefited from exemptions in the imports of trade associates.
He also imposes a series of specified lionies, snapping tariffs in steel, aluminum and autos, before launching an “autos, before launching an” autos to National “
The United States is a key market for the pharmaceutical industry, with a soriot speaking earlier in the year he hoped that the United States was representing almost half of Astrazeneca’s council at 2030.
The giant pharmaceutical says Tuesday it stays on track to achieve full target $ 80 billion in annual income of 2030.
This story originally shown Fortune.com
